Exclusive Rights for Drugs Leading to Skyrocketing Costs
There was a time when hospitals stocked Intensive Care Units with vasopressin like it was a common antibiotic. The inexpensive price tag supported buying the drug in bulk, and its use to fight sepsis and restore the flow of blood to vital organs like the brain made it an essential component of any crash cart.
Podcast: NC Senator Ralph Hise Talks Surprise Billing and the Proposal to Stop it
When it comes to consumerism in health care, one of the most important things we constantly urge for our readers is to be a knowledgeable consumer. That means doing the preparation in advance to know what type of out-of-pocket costs you might expect so that you can best prepare for your financial responsibility as a patient.
CDC: Americans Asking for Cheaper Drugs, Skipping Doses Due to Inflated Costs
While the toll taken on Americans by rising drug costs shouldn’t come as much of a surprise, a new report issued by the Centers for Disease Control and Prevention (CDC) has shed light on the depths of that impact.
PBMs Set to Defend Position as Senate Continues Drug Cost Probe
Just weeks after leadership from the world’s most influential pharmaceutical companies told the Senate Finance Committee that pharmacy benefit managers (PBMs) were to blame for high drug costs, an assortment of PBMs will appear before the same committee on April 9.
HB 450 Rewards Drug Makers For Their Part In The Opioid Crisis
The very same day Purdue Pharmaceuticals agreed to pay $270 million for their part in the opioid crisis in Oklahoma, lawmakers in North Carolina filed a bill that would actually reward pharmaceutical manufacturers for exacerbating the plague of opioids in our state.
This Time When My Water Breaks, Take Me To A Hospital Without Surprise Bills
By Rachel Bluth for Kaiser Health News When it comes to having a baby, that bundle of joy may bring an unexpected price tag that can affect parents’ future health care choices.